At follow-up, higher percentage of insulin treatment in T2DM patients was found in sub-group with low vaspin level than sub-group with high vaspin level (55.3% vs. 44.7%, P = 0.020). This evidence concerns the gene SERPINA12 and type 2 diabetes mellitus.